The anti-epileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABA- and glycine-gated currents
about
Antiepileptic drugs for Tourette's syndromeLevetiracetam monotherapy for epilepsyThe synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetamModifications of antiepileptic drugs for improved tolerability and efficacyLevetiracetam in the treatment of epilepsyThe Impact of Anti-Epileptic Drugs on Growth and Bone MetabolismAnti-convulsive and anti-epileptic properties of brivaracetam (ucb 34714), a high-affinity ligand for the synaptic vesicle protein, SV2A.Lasting consequences of traumatic events on behavioral and skeletal parameters in a mouse model for post-traumatic stress disorder (PTSD).Glycine receptors support excitatory neurotransmitter release in developing mouse visual cortexThe antiepileptic drug levetiracetam suppresses non-convulsive seizure activity and reduces ischemic brain damage in rats subjected to permanent middle cerebral artery occlusionA double-blind, placebo-controlled trial assessing the efficacy of levetiracetam extended-release in very heavy drinking alcohol-dependent patientsComplex febrile seizures: a practical guide to evaluation and treatment.Brivaracetam differentially affects voltage-gated sodium currents without impairing sustained repetitive firing in neuronsLevetiracetam: the profile of a novel anticonvulsant drug-part I: preclinical data.Levetiracetam inhibits glutamate transmission through presynaptic P/Q-type calcium channels on the granule cells of the dentate gyrus.Levetiracetam as an alternative therapy for Tourette syndrome.Region-specific changes in gene expression in rat brain after chronic treatment with levetiracetam or phenytoin.A prospective pilot study of levetiracetam for body dysmorphic disorder.New treatment options in status epilepticus: a critical review on intravenous levetiracetam.11-Deoxycortisol impedes GABAergic neurotransmission and induces drug-resistant status epilepticus in mice.Use of antiepileptic drugs for hyperkinetic movement disorders.Sequential intrarectal diazepam and intravenous levetiracetam in treating acute repetitive and prolonged seizuresAdditional antiepileptic mechanisms of levetiracetam in lithium-pilocarpine treated rats.Mechanisms of action for the commonly used antiepileptic drugs: relevance to antiepileptic drug-associated neurobehavioral adverse effects.Choosing antiepileptic drugs for developmentally normal children with specific epilepsy syndromes and behavioral disorders.Drug resistance in epilepsy: putative neurobiologic and clinical mechanisms.Levetiracetam has no acute effects on brain gamma-aminobutyric acid levels.Levetiracetam prevents kindling-induced asymmetric accumulation of hippocampal 7S SNARE complexes.Choosing the correct antiepileptic drugs: from animal studies to the clinic.Levetiracetam in the treatment of childhood epilepsy.GABA(A) receptor properties in catastrophic infantile epilepsyLevetiracetam: a comprehensive review.The effects of levetiracetam on alcohol consumption in alcohol-dependent subjects: an open label study.Is levetiracetam different from other antiepileptic drugs? Levetiracetam and its cellular mechanism of action in epilepsy revisited.Pharmacotherapy for children and adolescents with epilepsy.Post-stroke Movement Disorders: Clinical Manifestations and Pharmacological Management.Development of individualized medicine for epilepsy based on genetic information.Levetiracetam for the treatment of status epilepticus.Intravenous and Intramuscular Formulations of Antiseizure Drugs in the Treatment of Epilepsy.Status epilepticus in dogs and cats, part 2: treatment, monitoring, and prognosis.
P2860
Q24186745-1DCFC466-C985-4B8E-A6DF-A92743C35464Q24201619-75FF5E8E-34BC-40FF-BFE5-950130042F6FQ24561949-7845419B-F601-46D5-9514-64EA7970248DQ24651951-B734568F-531D-4A8A-A803-063B168397A1Q24656333-8F41FFD3-1791-456B-8A33-9E7231A69E87Q26739054-FEBFE6AC-BF89-4E58-A360-0C85EAC220BAQ28281249-D23EFF87-3B4C-4593-99A9-879571A93B77Q28482465-986C062D-253B-4F40-916F-DA318F3C4F32Q28512097-A68311C5-BB34-4DB7-A6B5-3D4DEF45B7CCQ28535091-7618E0BB-41C8-47FB-ADE4-2D53EAB1FEA4Q30417813-34325962-EE1C-4BD7-9050-C9C2952F6619Q30615069-E9E9B440-1971-42E8-B227-9EEA5D0E1DCEQ30627739-1EA8B55C-EB15-4F9B-B3FD-6A3EFAC6F4F9Q31110554-42E196E7-36D5-4FCA-BF67-6E176BDFD0D1Q33569536-D854177A-D731-4BD2-8D67-AB4830E2244EQ33966358-053C9AEE-E744-41C8-AAE4-BFC8D5DDE18FQ34118114-F4E16B2D-5074-4514-BC80-C37C1DEC77EAQ34139512-2EED6075-1EF0-4170-9A8C-BE447111C4DCQ34409333-F66258EB-994F-4A1E-A4F4-5B3D81C153ABQ34550965-D7972C92-55A1-4EC7-8775-09A7928D2F0BQ34829294-FA21F9FB-4D7E-44E6-9B52-56CBA872DCD2Q34985553-694A61E9-6E51-4128-AC19-6A702A643821Q35009654-94871804-D079-442A-B4FF-6E40BB840AABQ35939580-B780F9CC-411D-4AB2-85F2-327545DC4093Q35939596-0CE86ADB-8F88-477A-AD02-DD8110158905Q36157234-34A4E353-F514-41C7-BD31-5571EC9A4C75Q36854991-E276FB2A-2E07-4279-9DCF-74F6E15CE9CAQ36958952-53FFAF1C-0295-4D7A-AD9D-94E9C098D856Q37086272-81FDD6BA-3CD4-4552-8EB6-9DFCED26CDB1Q37126800-D7C32331-C292-4D57-B07B-A5BDA6F89172Q37137819-6597FF65-2D3A-42EA-B548-1BA670A16862Q37688063-1B21B161-A7F9-4B28-AE35-782CF261C661Q37735231-D71AA9BE-F3F8-4612-90A8-B9510C2F0DFBQ37823314-567E97B6-9930-4F61-9AEE-B3BD2B0A7F16Q37826193-77D3B19D-67CF-4BE2-8088-6B3464662C60Q38085546-B514774C-11B4-44F8-84BD-4E9C36F795C9Q38178326-B58E32F8-6376-4F47-828C-469B28E0676CQ38594849-10711F15-32FA-4D1C-903E-AA82E465320EQ38646868-C67B6DAC-BD65-4DC9-9416-DD855A0F002BQ38818494-CD058473-906C-46BA-96DA-7A608E8528DF
P2860
The anti-epileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABA- and glycine-gated currents
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
The anti-epileptic drug leveti ...... BA- and glycine-gated currents
@ast
The anti-epileptic drug leveti ...... BA- and glycine-gated currents
@en
type
label
The anti-epileptic drug leveti ...... BA- and glycine-gated currents
@ast
The anti-epileptic drug leveti ...... BA- and glycine-gated currents
@en
prefLabel
The anti-epileptic drug leveti ...... BA- and glycine-gated currents
@ast
The anti-epileptic drug leveti ...... BA- and glycine-gated currents
@en
P2093
P2860
P356
P1476
The anti-epileptic drug leveti ...... BA- and glycine-gated currents
@en
P2093
H Klitgaard
P Leprince
S Belachew
P2860
P304
P356
10.1038/SJ.BJP.0704766
P407
P577
2002-07-01T00:00:00Z